161 related articles for article (PubMed ID: 25664002)
1. Current evidence on the relationship between rs1256049 polymorphism in estrogen receptor-β gene and cancer risk.
Dai ZJ; Wang BF; Ma YF; Kang HF; Diao Y; Zhao Y; Lin S; Lv Y; Wang M; Wang XJ
Int J Clin Exp Med; 2014; 7(12):5031-40. PubMed ID: 25664002
[TBL] [Abstract][Full Text] [Related]
2. The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.
Fu C; Dong WQ; Wang A; Qiu G
Tumour Biol; 2014 Aug; 35(8):8319-28. PubMed ID: 24859835
[TBL] [Abstract][Full Text] [Related]
3.
Wang LN; Wang F; Liu J; Jin YH; Fang C; Ren XQ
Front Physiol; 2017; 8():1081. PubMed ID: 29326607
[No Abstract] [Full Text] [Related]
4. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
5. Association between the Estrogen receptor β rs1256049 polymorphism and prostate cancer risk:a meta-analysis.
Gazzaz H; El Feniche M; Ameur A; Dami A
Ann Biol Clin (Paris); 2023 Jul; 81(3):280-288. PubMed ID: 37329151
[TBL] [Abstract][Full Text] [Related]
6. ESR2 polymorphisms on prostate cancer risk: A systematic review and meta-analysis.
Chang X; Wang H; Yang Z; Wang Y; Li J; Han Z
Medicine (Baltimore); 2023 Jun; 102(23):e33937. PubMed ID: 37335680
[TBL] [Abstract][Full Text] [Related]
7. The association between RFC1 G80A polymorphism and cancer susceptibility: Evidence from 33 studies.
Huang X; Gao Y; He J; Cai J; Ta N; Jiang H; Zhu J; Zheng J
J Cancer; 2016; 7(2):144-52. PubMed ID: 26819637
[TBL] [Abstract][Full Text] [Related]
8. Association between X-ray repair cross-complementing group 1(XRCC1) Arg399Gln polymorphism and endometriosis: A systematic review and meta-analysis.
Lv MQ; Wang J; Yu XQ; Hong HH; Ren WJ; Ge P; Zhou DX
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():12-20. PubMed ID: 28926725
[TBL] [Abstract][Full Text] [Related]
9. Relationship between Aurora-A V57I Polymorphism and the Risk of Cancer: A Meta-Analysis and Trial Sequential Analysis.
Chen G; Hu C; Song Y; Xiu M; Zhang Y; Lai P; Li Y; Liu X; Huang P
J Cancer; 2020; 11(11):3225-3234. PubMed ID: 32231728
[No Abstract] [Full Text] [Related]
10. Current evidence on the relationship between two common polymorphisms in NPAS2 gene and cancer risk.
Wang B; Dai ZM; Zhao Y; Wang XJ; Kang HF; Ma XB; Lin S; Wang M; Yang PT; Dai ZJ
Int J Clin Exp Med; 2015; 8(5):7176-83. PubMed ID: 26221256
[TBL] [Abstract][Full Text] [Related]
11. Aurora-A V57I (rs1047972) polymorphism and cancer susceptibility: a meta-analysis involving 27,269 subjects.
Tang W; Qiu H; Jiang H; Wang L; Sun B; Gu H
PLoS One; 2014; 9(3):e90328. PubMed ID: 24598702
[TBL] [Abstract][Full Text] [Related]
12. Associations between estrogen receptor-beta polymorphisms and endometriosis risk: a meta-analysis.
Guo R; Zheng N; Ding S; Zheng Y; Feng L
Diagn Pathol; 2014 Sep; 9():184. PubMed ID: 25257822
[TBL] [Abstract][Full Text] [Related]
13. Association between MDM2 rs 2279744 polymorphism and breast cancer susceptibility: a meta-analysis based on 9,788 cases and 11,195 controls.
Gao J; Kang AJ; Lin S; Dai ZJ; Zhang SQ; Liu D; Zhao Y; Yang PT; Wang M; Wang XJ
Ther Clin Risk Manag; 2014; 10():269-77. PubMed ID: 24790452
[TBL] [Abstract][Full Text] [Related]
14. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Luo T; Chen J; Liu JJ; Li H; You XM; Wang HL; Zhu SL; Li LQ
Onco Targets Ther; 2016; 9():4483-9. PubMed ID: 27499641
[TBL] [Abstract][Full Text] [Related]
15. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
[TBL] [Abstract][Full Text] [Related]
16. ASSOCIATION OF TNF- α-308G>A POLYMORPHISM WITH SUSCEPTIBILITY TO CELIAC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Aflatoonian M; Moghimi M; Akbarian-Bafghi MJ; Morovati-Sharifabad M; Jarahzadeh MH; Neamatzadeh H
Arq Gastroenterol; 2019 May; 56(1):88-94. PubMed ID: 31141070
[TBL] [Abstract][Full Text] [Related]
17. The RNASEL -1385G/A polymorphism is associated with risk of prostate cancer in Africans.
Liu X; Zheng D; Lu G; Yang B
Onco Targets Ther; 2018; 11():97-102. PubMed ID: 29317837
[TBL] [Abstract][Full Text] [Related]
18. Association between IL-17A G197A polymorphism and gastric cancer risk: an updated meta-analysis based on 6,624 cases and 7,631 controls.
Hu L; Kong F; Pan Y
Onco Targets Ther; 2018; 11():703-710. PubMed ID: 29440917
[TBL] [Abstract][Full Text] [Related]
19. Investigation of
Qiu H; Cheng C; Wang Y; Kang M; Tang W; Chen S; Gu H; Liu C; Chen Y
Onco Targets Ther; 2016; 9():6641-6650. PubMed ID: 27822068
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor α -308 G>A polymorphisms and cervical cancer risk: a meta-analysis.
Ding B; Fu S; Wang M; Yue C; Wang W; Zhou D; Zhang Z; Han S
Int J Gynecol Cancer; 2012 Feb; 22(2):213-9. PubMed ID: 22146770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
